iRhythm
Corporate brand
UnclaimediRhythm provides an end-to-end cardiac monitoring service built around Zio ECG monitors and FDA-cleared deep-learned AI.
Last updated September 10, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
iRhythm offers an end-to-end cardiac monitoring service that combines Zio ECG monitors, data analysis, and reporting in a single service. The service uses an FDA-cleared deep-learned AI algorithm that the company states is clinically proven to be as accurate as expert cardiologists, and combines up to 14 days of uninterrupted ECG data with intelligent algorithms and expert clinical review to deliver actionable data for clinicians.
Products and positioning
iRhythm positions its monitoring service as delivering precision, accuracy, and actionable data for cardiac arrhythmia diagnosis, with an FDA-cleared deep-learned AI algorithm and high patient compliance.
iRhythm monitoring service
An end-to-end cardiac monitoring service that brings together devices, data analysis, and reporting in a single service, using advanced Zio ECG monitors and data management solutions.
Zio ECG monitors
Advanced, simple-to-use ECG monitors designed to be comfortable and easy to wear for better patient satisfaction and compliance.
Controversies
Recent events
Sources5 sources
- 1Heart Monitor Patch & Device for Arrhythmia Detection | Zio® ECG Monitors by iRhythmirhythmtech.com
- 2FDA-cleared, advanced AI | Zio® ECG Monitors | iRhythmirhythmtech.com
- 3Who We Are – Innovating the Future of Cardiac Monitoring | iRhythmirhythmtech.com
- 4Cardiac Monitoring Solutions & Services | iRhythmirhythmtech.com
- 5Shareholder lawsuit against iRhythmlawstreetmedia.com
Cite this profile: Cite the canonical profile. /brand-wiki/irhythm · Editorial policy · How profiles are compiled